GenSight Biologics
SIGHT.PA
#10724
Rank
A$31.64 M
Marketcap
A$0.13
Share price
3.20%
Change (1 day)
-29.75%
Change (1 year)

Earnings for GenSight Biologics (SIGHT.PA)

Earnings in 2025: -A$21 Million

According to GenSight Biologics's latest financial reports the company's current earnings are A$0 Million. In 2025 the company made an earning of -A$21 Million, an increase over its 2024 earnings that were of -A$21.6 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for GenSight Biologics from 2013 to 2025

Annual earnings

Year Earnings Change
2025-A$21 Million-2.77%
2024-A$21.6 Million-49.81%
2023-A$43.02 Million-2.16%
2022-A$43.97 Million-8.58%
2021-A$48.1 Million-22.54%
2020-A$62.09 Million21.01%
2019-A$51.31 Million-9.66%
2018-A$56.8 Million32.28%
2017-A$42.94 Million24.57%
2016-A$34.47 Million55.57%
2015-A$22.16 Million84%
2014-A$12.05 Million112.64%
2013-A$5.67 Million